Researchers at the University of Virginia School of Medicine have shed light on how cancers hijack the body’s natural wound-healing response to grow and spread. The researchers have identify specific processes within endothelial cells the cells that line blood vessels that tumors use to build out their own blood supply.
Tumor is not just a ball
These processes are normally use by the body to repair tissue, heal injuries and grow new blood vessels, but tumors co-opt them to create blood vessels that will nourish them and feed their growth. A tumor is not just a ball of malignant cancer cells, right? It’s almost like a little miniature organ that creates or co-opts its own blood supply.
A tumor steals as it’s growing and developing. It steals physiological processes that help it along. And one of those processes is wound healing. And that’s what we’ve been studying how the tumor subverts this process of wound healing. Intriguingly, the research suggests that endothelial cells have a previously unknown degree of specialization that varies among individual cells.
Some appear to have a better ability to form new blood vessels than others. PhD student James V. McCann was able, using some cutting edge methodologies; hence to stratify various endothelial cells base on what they called their “functional diversity.” This was base partly on the amount of a particular type of microRNA; also the gene it targets, inside the cells.
Controlling the expression of genes
MicroRNAs are tiny molecules responsible for controlling the expression of genes, a process that goes haywire in cancer. Endothelial cells that were rich in this particular microRNA struggle to sprout new blood vessels; hence they find, while those with less were better at it. The amount vary even among individual endothelial cells within a developing tumor.
Looking at breast cancer samples, the researchers were able to determine that patients with the best outcomes; so were those with the highest levels of the microRNA. Further, delivering the microRNA to the endothelial cells of a developing tumor in mice significantly reduce the number of blood vessels and slow overall tumor growth, McCann found.
The researchers caution that there are obstacles that prevent their work from being immediately applicable in people. Treating breast cancer won’t be as simple as giving patients more of this specific microRNA. However, the scientists are excite to have shed light on a vascular direct process that cancer exploits to create its own blood supply; also to have give scientists new leads in the battle against the disease.